β3 tyrosine phosphorylation in αIIbβ3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling

Thrombosis and Haemostasis

Volumn 86, Issue 1, 2001, Pages 246-258

  Phillips, D R ^a   Nannizzi Alaimo, L ^a   Srinivasa Prasad, K S ^a  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Arterial thrombosis; Platelets; Signaling mechanisms; Tyrosine phosphorylation; IIb 3 integrin

Indexed keywords

ABCIXIMAB; ADENOSINE DIPHOSPHATE; COLLAGEN; EPTIFIBATIDE; FIBRINOGEN; FIBRINOGEN RECEPTOR; INTEGRIN; MYOSIN; PHENYLALANINE; PROTEIN SHC; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; THROMBIN; TIROFIBAN; TYROSINE; VON WILLEBRAND FACTOR; BETA3 INTEGRIN; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BETA CHAIN; BLEEDING DISORDER; BLOOD CLOT RETRACTION; CONFERENCE PAPER; CORONARY ARTERY THROMBOSIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW; THROMBOCYTE ACTIVATION;

AMINO ACID MOTIFS; ANIMALS; ANTIGENS, CD; HUMANS; INTEGRIN BETA3; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TYROSINE;

EID: 0034742636     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616222     Document Type: Conference Paper

References (105)

1. Platelet integrin GPIIb/IIIa: Structure-function correlations. An update and lessons from other integrins
2. Integrin signaling in vascular biology
3. Integrin signaling: The platelet paradigm
4. Signaling through platelet integrin alphaIIbbeta3: Inside-out, outside-in, and sideways
5. Evidence that the integrin beta3 and beta5 subunits contain a metal ion-dependent adhesion site-like motif but lack an I domain
6. Integrin-mediated cell adhesion: The extracellular face
7. Integrin-dependent control of translation: Engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets
8. Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function
9. Outside-in integrin signal transduction. AlphaIIbbeta3 (GP IIb-IIIa) tyrosine phosphorylation induced by platelet aggregation
10. Identification of Shc as the primary protein binding to the tyrosine-phosphorylated beta3 subunit of alphaIIbbeta3 during outside-in integrin platelet signaling
11. Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions
12. Ser-752→Pro mutation in the cytoplasmic domain of integrin beta3 subunit and defective activation of platelet integrin alphaIIbbeta3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia
13. Integrins: Versatility, modulation, and signaling in cell adhesion
14. Ligand binding to integrins
15. A structural basis for integrin activation by the cytoplasmic tail of the alphaIIb-subunit
16. Structures of the platelet calcium- and integrin-binding protein and the alphaIIb-integrin cytoplasmic domain suggest a mechanism for calcium-regulated recognition; Homology modelling and NMR studies
17. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling
18. Antibody-detectable changes in fibrinogen adsorption affecting platelet activation on polymer surfaces
19. Ligand bridging mediates integrin alphaIIbbeta3 (platelet GPIIa-IIIa) dependent homotypic and heterotypic cell-cell interactions
20. A conformation-dependent epitope of human platelet glycoprotein IIIa
21. Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion
22. Bidirectional transmembrane modulation of integrin alphaIIbbeta3 conformations
23. GPIIb-IIIa: The responsive integrin
24. Signal transduction by receptors with tyrosine kinase activity
25. Signaling by receptor tyrosine kinases
26. Glycoprotein IIIa is phosphorylated in intact human platelets
27. Phosphorylation of human platelet glycoprotein IIIa (GPIIIa). Dissociation from fibrinogen receptor activation and phosphorylation of GPIIIa in vitro
28. Phosphorylation of the fibronectin receptor complex in cells transformed by oncogenes that encode tyrosine kinases
29. Altered localization and cytoplasmic domain-binding properties of tyrosine-phosphorylated beta1 integrin
30. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation
31. Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin
32. The PTB domain: A new protein module implicated in signal transduction
33. A single point mutation switches the specificity of group III Src homology (SH)2 domains to that of group I SH2 domains
34. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases
35. Platelet adhesion receptors
36. Priming of platelet alphaIIbbeta3 by oxidants is associated with tyrosine phosphorylation of beta3
37. Unexpected crucial role of residue 225 in serine proteases
38. Requirement of the NPXY motif in the integrin beta3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo
39. Use of a beta1 integrin-deficient human T cell to identify beta1 integrin cytoplasmic domain sequences critical for integrin function
40. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
41. Integrin cytoplasmic domain-binding proteins
42. Beta3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta3 subunit
43. A conserved sequence motif in the integrin beta3 cytoplasmic domain is required for its specific interaction with beta3-endonexin
44. Identification of a novel calcium-binding protein that interacts with the integrin alphaIIb cytoplasmic domain
45. Calcium-dependent properties of CIB binding to the integrin alphaIIb cytoplasmic domain and translocation to the platelet cytoskeleton
46. Direct binding of the platelet integrin alphaIIbbeta3 (GPIIb-IIIa) to talin. Evidence that interaction is mediated through the cytoplasmic domains of both alphaIIb and beta3
47. The talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation
48. Rh-related antigen CD47 is the signal-transducer integrin-associated protein
49. Thrombspondin acts via integrin-associated protein to activate the platelet integrin alphaIIbbeta3
50. cDNA cloning and expression of platelet p24/CD9. Evidence for a new family of multiple membrane-spanning proteins
51. Identification of membrane proteins mediating the interaction of human platelets
52. Self-association of bound fibrinogen on platelet surfaces
53. Cytochalasin D and E: Effects on fibrinogen receptor movement and cytoskeletal reorganization in fully spread, surface-activated platelets: A correlative light and electron microscopic investigation
54. Distinct functions of integrin alpha and beta subunit cytoplasmic domains in cell spreading and formation of focal adhesions
55. Dissecting clot retraction and platelet aggregation. Clot retraction does not does not require an intact fibrinogen gamma chain C terminus
56. Active GPIIb-IIIa conformations that link ligand interaction with cytoskeletal reorganization
57. Not all Shc's roads lead to Ras
58. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression
59. Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras
60. Direct interaction between Shc and the platelet-derived growth factor beta-receptor
61. Interaction of Shc with the zeta chain of the T cell receptor upon T cell activation
62. B cell antigen receptor cross-linking induced phosphorylation of the p21ras oncoprotein activators SHC and mSOS1 as well as assembly of complexes containing SHC, GRB-2, mSOS1, and a 145-kDa tyrosine-phosphorylated protein
63. Protein interactions of Src homology 2 (Sh2) domain-containing inositol phosphate (SHIP): Association with Shc displaces SHIP from FcgammaRIIB in B cells
64. Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase
65. Signal transduction by the alpha6beta4 integrin: Distinct beta4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes
66. Distinct roles of the adaptor protein shc and focal adhesion kinase in integrin signaling to ERK
67. Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc
68. SHC-alpha5beta1 integrin interactions regulate breast cancer cell adhesion and motility
69. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN
70. Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C
71. Thrombin induces activation of p38 MAP kinase in human platelets
72. Stimulation by ceramide of phospholipase A2 activation through a mechanism related to the phospholipase C-initiated signaling pathway in rabbit platelets
73. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets
74. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex
75. Adhesive properties of the beta3 integrins: Comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells
76. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor
77. Inhibition of platelet adhesion during cardiopulmonary bypass reduces postoperative bleeding
78. Reorganization of myosin in surface-activated spreading platelets
79. Simultaneous digital imaging analysis of cytosolic calcium and morphological change in platelet activated by surface contact
80. Adhesive signaling in platelets
81. Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors
82. Prostacyclin (prostaglandin I2, PG12) inhibits platelet adhesion and thrombus formation on subendothelium
83. Outside-In signaling of soluble and solid-phase fibrinogen through integrin alphaIIbbeta3 is different and cooperative with each other in a megakaryoblastic leukemia cell line, CMK
84. Differential activation and redistribution of c-Src and Fyn in platelets, assessed by MoAb specific for C-terminal tyrosine- dephosphorylated c-Src and Fyn
85. Inducible tyrosine phosphorylation of the beta3 integrin requires the alphaV integrin cytoplasmic tail
86. Distinct involvement of beta3 integrin cytoplasmic domain tyrosine residues 747 and 759 in integrin-mediated cytoskeletal assembly and phosphotyrosine signaling
87. Modulation of beta1 A integrin functions by tyrosine residues in the beta1 cytoplasmic domain
88. The cytoplasmic tyrosines of integrin subunit beta1 are involved in focal adhesion kinase activation
89. On the role of the platelet membrane skeleton in mediating signal transduction. Association of GP IIb-IIIa, pp60c-src, pp62c-yes, and the p21ras GTPase-activating protein with the membrane skeleton
90. Hematopoietic reconstruction of SLP-76 corrects hemostasis and platelet signaling through alphaIIbeta3 and collagen receptors
91. The molecular adapter SLP-76 relays signlas from platelet integrin alphaIIbbeta3 to the actin cytoskeleton
92. Phosphorylated pleckstrin induces cell spreading via an integrin-dependent pathway
93. SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility
94. A novel integrin-activated pathway forms PKB/Akt-stimulatory phosphatidylinositol 3,4-bisphosphate via phosphatidylinositol 3-phosphate in platelets
95. pp60c-src associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of alphaIIbbeta3 integrin in human platelets
96. Protein kinase C phosphorylation of syntaxin 4 in thrombin-activated human platelets
97. Integrin signaling
98. Integrin polymorphisms as risk factors for thrombosis
99. Platelet glycoprotein plymorphisms as risk factors for thrombosis
100. Increased platelet aggregability associated with platelet GPIIIa P1A2 polymorphism: The Framingham Offspring Study
101. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts
102. Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?
103. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
104. Oral platelet glycoprotein IIb/IIIa inhibition
105. Learning from the recently completed oral glycoprotein IIb/IIIa receptor anatagonist trials